Current Opinion in Cardiology

Article	Citations
The role of artificial intelligence in early detection and intervention of coronary artery disease	28
Genetics of sudden cardiac death	20
Editorial: from albuminuria to uric acid – emerging risk factors beyond lipids	17
Editorial introductions	15
Assessment and management of neonates with unrepaired congenital heart disease	15
REVIVED BCIS-2: update and key learnings	14
Role of medical management of cardiogenic shock in the era of mechanical circulatory support	13
Device therapy for heart failure management	13
Vascular regenerative cells in cardiometabolic disease	13
Pemafibrate and other triglyceride-lowering therapies to reduce risk of cardiovascular and metabolic disease	13
Advances in device-based therapies for cardiorenal syndrome	13
Donation after circulatory determination of death in heart transplant: impact on current and future allocation policy	12
Editorial introductions	12
Low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol and apolipoprotein B for cardiovascular care	11
Epigenetic remodeling in heart failure with preserved ejection fraction	11
Editorial introductions	11
Team-based strategies to prevent heart failure	10
Multimodality cardiovascular imaging in hypertension	10
Wellness and burnout in cardiac surgery: not black and white	10
Clinical considerations and pathophysiological associations among obesity, weight loss, heart failure, and hypertension	10
Cardiac phenotypes in LMNA mutations	10
Cardiac selectivity in pulsed field ablation	10
Imaging of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy	10
The impact of transcatheter edge-to-edge repair on mitral valve annular geometry	10
Radiofrequency lesion formation prediction with contact force versus local impedance	10

Mapping and ablation of intramural premature ventricular complexes: state-of-the-art review	9
Sleep apnea and cardiovascular risk	9
Bicuspid aortic valve associated aortopathy: 2022 guideline update	9
Editorial introductions	9
Management of hypertension in heart transplant recipients: an ongoing conundrum	9
Near infrared spectroscopy in the pediatric cardiac intensive care unit: accurately interpreting the data	9
Impact of glucagon-like peptide-1 receptor agonists on hypertension management: a narrative review	8
Expanding revascularization trials to women and underserved minorities and shifting to patient-centered outcomes: RECHARGE trials program	8
The mitral valve in hypertrophic cardiomyopathy	8
Is the world ready for the STICH 3.0 trial?	8
New wrinkles in hypertension management 2022	8
Management of difficult coronary anatomy during transcatheter aortic valve implantation: what are the key issues?	8
Weight loss and atrial fibrillation: a review	8
Integration of palliative care across the spectrum of heart failure care and therapies: considerations, contemporary data, and challenges	8
Factor XI inhibitors: what should clinicians know	7
Coronary microvascular dysfunction and heart failure with preserved ejection fraction: what are the mechanistic links?	7
Electrographic flow mapping of atrial fibrillation	7
Disparity issues in coronary artery surgery	6
Update on the molecular landscape of thoracic aortic aneurysmal disease	6
Editorial introductions	6
Clinical trials of cell therapy for heart failure: recent results warrant continued research	6
Percutaneous left atrial appendage closure for stroke prevention in atrial fibrillation: who should receive it in current clinical practice?	6
Bad behavior in healthcare: an insidious threat to patients, staff, and organizations	6
Albuminuria and cardiorenal risk	6
Symptoms, coronary artery disease and percutaneous coronary intervention: connecting the dots	6
Electronic health strategies to improve medication adherence in patients with cardiometabolic disease: current status and future directions	6
Improving diversity in cardiac surgery clinical trials with ROMA:Women as an exemplar	6
Promoting gender diversity and ergonomic equity in the cardiac surgery operating room	6
When should the tricuspid valve be repaired during mitral valve repair?	6
Editorial introductions	6
Artificial sweeteners and cardiovascular risk	6
Postmyocardial infarction ventricular septal rupture: optimizing surgical timing and repair	5
Peripheral arterial disease and hypertension	5
Coronary artery calcium and sudden cardiac death: current evidence and future directions	5
Clinical impact of genetic testing for lipid disorders	5
Mitral valve surgery after failed transcatheter edge-to-edge repair: a review and word of caution	5
Left main revascularization guidelines: navigating the data	5
How to deal with nonsevere stenoses in coronary artery bypass grafting – a critical perspective on competitive flow and surgical precision	5
Destination LVAD therapy in the current era of the heart transplant allocation system	5
Recent advances in cardiac imaging: emerging use of three-dimensional visualization for analyzing complex cardiovascular anatomy	5
Influenza vaccination in mitigating vascular events and risk	5
The management of new-onset atrial fibrillation in critical illness: an update on current therapeutic options	5
Robotic mitral valve surgery: evolving history, techniques, and training paths	5
Long noncoding RNAs in cardiovascular disease	5
High lipoprotein(a) is a risk factor for peripheral artery disease, abdominal aortic aneurysms, and major adverse limb events	5
Management of pregnancy in left ventricular assist device and heart transplant recipients: a concise review	5
Patient selection in robotic mitral valve surgery	5
Editorial introductions	4
Editorial introductions	4
Editorial: the year in lipids and emerging risk factors	4

Semaglutide for weight loss and cardiometabolic risk reduction in overweight/obesity	4
Recent advances in multimodal imaging in tetralogy of fallot and double outlet right ventricle	4
Building resilient heart center teams	4
Statin-Associated muscle symptoms and vitamin D supplementation	4
Teaching minimally invasive coronary artery bypass grafting: a structured framework for well tolerated adoption and training	4
A tale of two balloons: technical and procedural difference between cryoballoon systems: Erratum	4
The landscape of cardiogenic shock: epidemiology and current definitions	4
Double outlet right ventricle – the 50% rule has always been about the conus	4
Pharmacogenetics of cardiovascular drugs	4
From remnant cholesterol to lipoprotein(a) – emerging risk factors for cardiovascular diseases beyond low density lipoprotein: Erratum	4
Short and long-term complications of hypertensive disorders of pregnancy: lifelong cardiovascular risks we cannot ignore	3
Broadening the applicability of coronary surgery from minimally invasive approaches to the modern treatment of ventricular septal rupture	3
Hypertrophic cardiomyopathy and competitive sports: let ‘em play?	3
Risk stratification for sudden death in congenital heart disease: bridging evidence, uncertainty, and individual decision-making	3
Rethinking atherosclerotic cardiovascular disease prevention in the era of expanding therapies: could plaque stabilization reduce the need for lifelong treatments and polypharmacy?	3
Intravenous iron in patients with iron deficiency and heart failure: a review of modern evidence	3
Selection of percutaneous mechanical circulatory support in cardiogenic shock: patient-specific considerations and insights from contemporary clinical data	3
Coronary artery calcium testing in young adults	3
Cardiac sarcoidosis; update for the heart failure specialist	3
Are serum uric acid levels predictors of cardiovascular risk? An update	3
Left ventricular function recovery in Takotsubo syndrome, clinical and pathophysiological insights: a state-of-the-art review	3
Introduction to the coronary artery surgery section	3
Editorial: Gene-based renaming of human diseases	3
Developing a professional and career identity: it's a journey to enjoy	3
From C-reactive protein to climate change: risk predictors for cardiovascular diseases beyond low-density lipoprotein cholesterol	3
The clinical utility of assessing coronary vasomotor dysfunction in angina with nonobstructive coronary artery	3
Worsening heart failure: a concept in evolution	3
Clonal hematopoiesis: the nonhereditary genetics of age-associated cardiovascular disease	3
Perspectives on pulsed field ablation: how to judge endpoints	3
Hypertension in chronic kidney disease and future heart failure	3
Ultrasound-Based assessment of systemic congestion in pulmonary hypertension	3
The role of imaging in risk assessment for pulmonary arterial hypertension	3
The influence of age and sex on the prognostic importance of traditional cardiovascular risk factors, selected circulating biomarkers and other markers of subclinical cardiovascular damage	3
Hypertension in atherosclerotic cardiovascular disease: insights into epidemiology, management strategies, and outcomes	3
Congenitally corrected transposition: not correct at all	3
Nuclear imaging techniques for cardiac amyloidosis	3
Transfusion thresholds in acute coronary syndromes	3
Anesthetic management in patients with long QT and Brugada syndromes	3
Complex issues in coronary artery surgery	3
New therapies to treat cardiac amyloidosis	3
Closing the care gap: combining enhanced recovery with minimally invasive valve surgery	3
Beyond Weight Loss: the Emerging Role of Incretin-Based Treatments in Cardiometabolic HFpEF	3
Diet and vascular risk	2
Editorial introductions	2
Editorial introductions	2
A review of the contemporary use of inotropes in patients with heart failure	2
Neurodevelopmental outcomes in congenital heart disease: modifiable and nonmodifiable substrates	2
Which lesions are not amenable to tricuspid clipping?	2
Genetics of atrial fibrillation	2
Editorial introductions	2
Completed and ongoing trials in minimally invasive cardiac surgery coronary surgery	2
Genetic aortopathies: a case-based approach to multidisciplinary program development	2
Advances in contemporary medical management to treat patients with heart failure	2
RNA therapeutics in cardiovascular medicine	2
Cardiovascular utility of single cell RNA-Seq	2
The role of multimodality imaging in patients with heart failure with reduced and preserved ejection fraction	2
Adverse pregnancy outcomes and future risk of heart failure	2
Complete revascularization with percutaneous coronary intervention for acute coronary syndromes presenting with multivessel disease	2
High reliability pediatric heart centers: Always working toward getting better	2
A deep dive into the percutaneous mitral valve data	2
Treatment of transthyretin cardiac amyloidosis	2
Editorial introductions	2
When is imaging needed to assess the response to treatment in cardiac amyloidosis	2
Treatment options to break the cycle of recurrent pericarditis	2
Pulmonary hypertension in 2025: next steps?	2
Predictive utility of remnant cholesterol in atherosclerotic cardiovascular disease	2
Robotic mitral surgery: recent advances and outcomes	2
From remnant cholesterol to lipoprotein(a) – emerging risk factors for cardiovascular diseases beyond low density lipoprotein	2
Structural genomic variants in thoracic aortic disease	2
2023 Update on equity, diversity, and inclusion in Canadian cardiac surgery	2
Metabolic basis of cardiac dysfunction in cancer patients	2
HIV and hypertension epidemiology	2
Revascularization in chronic coronary syndrome: shifts in clinical practice guidelines	2
Myocardial infarction with nonobstructive coronary arteries: the need for precision medicine	2
Ascending aortic intramural hematoma: current concepts	2
New concepts in heart failure with preserved ejection fraction and hypertension	2
Adding the patient perspective: the necessity of patient reported outcomes in cardiac surgery clinical trials	2
Anticoagulation for rheumatic mitral stenosis, INVICTUS in perspective	2
Ablation options for sub-epicardially located ventricular substrates responsible for ventricular tachycardia: where is it all headed?	2
No-touch saphenous vein: current understanding of the conduit ‘less handled’	2

Pulmonary arterial hypertension in pregnancy	2
Heart transplant donation after circulatory death: current status and implications	2
Controversies related to renal artery denervation and devices	2
Editorial introductions	2
Lipoprotein(a) is a highly atherogenic lipoprotein: pathophysiological basis and clinical implications	2